𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Living and deceased donor liver transplantation for unresectable hepatoblastoma at a single center

✍ Scribed by Alejandro Mejia; Alan N Langnas; Byers W Shaw; Clarivet Torres; Debra L Sudan

Book ID
110889591
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
84 KB
Volume
19
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatopulmonary syndrome after living do
Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: A single-center experience
✍ Elizabeth J. Carey; David D. Douglas; Vijayan Balan; Hugo E. Vargas; Thomas J. B πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

Hepatopulmonary syndrome (HPS) is a progressive, debilitating complication of end-stage liver disease. In contrast to the well-established reversal of HPS after deceased donor liver transplantation (DDLT), little has been written about the natural course of HPS after the newer procedure of living do

Living donor liver transplantation versu
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: Comparable survival and recurrence
✍ Lakhbir Sandhu; Charbel Sandroussi; Markus Guba; Markus Selzner; Anand Ghanekar; πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 901 KB

Several studies have reported higher rates of recurrent hepatocellular carcinoma (HCC) after living donor liver transplantation (LDLT) versus deceased donor liver transplantation (DDLT). It is unclear whether this difference is due to a specific biological effect unique to the LDLT procedure or to o

Living donor liver transplantation for h
Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report
✍ Massimo MalagΓ³; Georgios C. Sotiropoulos; Silvio Nadalin; Camino Valentin-Gamazo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 100 KB

Liver transplantation (LT) is the treatment of choice for early hepatocellular carcinoma (HCC) in patients with end-stage liver disease but is limited by the availability of donor organs. Living donor liver transplantation (LDLT) represents an alternative therapeutic option for patients with disease